Scynexis (SCYX) Preferred Stock Liabilities (2013 - 2014)
Scynexis (SCYX) reported Preferred Stock Liabilities of $4.2 million for Q1 2014, little changed quarter-over-quarter from $4.2 million in Q4 2013.
Scynexis (SCYX) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
Scynexis has reported Preferred Stock Liabilities for 2 years, with the latest figure at $4.2 million in Q1 2014.
- For the quarter ending Q1 2014, Preferred Stock Liabilities changed N/A year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2014 stood at $4.2 million (changed N/A YoY), and the FY2013 full-year result was $4.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2014 stood at $4.2 million, roughly flat from $4.2 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $4.2 million in Q4 2013, with the low at $4.2 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Scynexis | 228.29 Mn | 169.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 4.22 Mn |
| Dec 31, 2013 | 4.22 Mn |